Dr Sophie Vieujean on older adults with IBD and clinical trials episode artwork

EPISODE · May 4, 2022 · 16 MIN

Dr Sophie Vieujean on older adults with IBD and clinical trials

from The Lancet Healthy Longevity in conversation with · host The Lancet Healthy Longevity

Dr Sophie Vieujean (Liège University Hospital) joins Ben Burwood to discuss her Review detailing the issues facing the inclusion of older adults with inflammatory bowel disease in clinical trials.  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published May 4, 2022

Embed this episode

NOW PLAYING

Dr Sophie Vieujean on older adults with IBD and clinical trials

0:00 16:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet Healthy Longevity in conversation with?

This episode is 16 minutes long.

When was this The Lancet Healthy Longevity in conversation with episode published?

This episode was published on May 4, 2022.

Can I download this The Lancet Healthy Longevity in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!